SHELDON KAPLAN to Cefotaxime
This is a "connection" page, showing publications SHELDON KAPLAN has written about Cefotaxime.
Connection Strength
0.324
-
Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms. Pediatr Infect Dis J. 1990 Nov; 9(11):810-4.
Score: 0.088
-
Management of pneumococcal meningitis. Pediatr Infect Dis J. 2002 Jun; 21(6):589-91; discussion 613-4.
Score: 0.049
-
Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J. 2001 Apr; 20(4):392-6.
Score: 0.045
-
Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections. Antimicrob Agents Chemother. 1996 Apr; 40(4):895-8.
Score: 0.032
-
Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994 May; 38(5):918-23.
Score: 0.028
-
Meningitis due to Staphylococcus aureus in children. Clin Infect Dis. 1993 Jun; 16(6):766-71.
Score: 0.026
-
Treatment of meningitis and other infections due to ampicillin-resistant Haemophilus influenzae type b in children. Rev Infect Dis. 1991 Mar-Apr; 13(2):197-200.
Score: 0.023
-
Serious pediatric infections. Am J Med. 1990 Apr 09; 88(4A):18S-24S.
Score: 0.021
-
Effect of dexamethasone or HWA-138 in combination with antibiotics in experimental Haemophilus influenzae type b infection. Antimicrob Agents Chemother. 1991 Oct; 35(10):1980-4.
Score: 0.006
-
Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr Infect Dis J. 1987 Jun; 6(6):501-5.
Score: 0.004